Allarity Therapeutics A/S Pipeline Insight and Competitive Landscape, 2023
Powered by ![]()
Unlock hidden opportunities in the Medical Devices industry
Empower your strategies with our Allarity Therapeutics A/S Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions.
Allarity Therapeutics A/S (Allarity) is formerly Oncology Venture A/S, is a late clinical-stage, precision medicine company. Its pipeline products include dovitinib, to treat second line ovarian cancer; stenoparib, to treat third line ovarian cancer; ixempra, to treat second line metastatic breast cancer; 2X-111, to treat primary brain cancer. The company’s drug response predictor (DRP) platform is used to create drug specific diagnostics. Its diagnostics platform also helps in accelerating clinical development. The company’s pipeline program is being co-developed with a drug specific DRP companion diagnostic to select and treat patients most likely to benefit from treatment. Allarity also carries out phase 1 and phase 2 clinical trials. Its brands include IXEMPRA, LiPlaCis, and DRP. Allarity is headquartered in Horsholm, Denmark.
GlobalData’s Medical Devices company profile report, “Allarity Therapeutics A/S Pipeline Insight and Competitive Landscape, 2023″ provides information about the company overview and analysis on their pipeline products.
This company profile report provides key information and data related to:
- Top level information about the company performance and their pipeline products
- Review details of major pipeline products which include developmental activities including pipeline territories, and estimated approval dates
This company profile report enables you to:
- Access significant analysis and insights to improve R&D strategies
- Formulate market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
The GlobalData Differentiation
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.
The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:
- 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
- 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports
- 79,000+ medical equipment company profiles
- 5,600+ company profiles of medical equipment manufacturers in China and India
- 2,200+ company profiles of medical equipment manufacturers in Japan
- 1,200+ companies’ revenue splits and market shares
- 1,600+ quarterly and annual medical equipment company financials
- 850+ medical equipment company SWOTs
- 38,000+ pipeline product profiles
- 91,600+ marketed product profiles
- 65,600+ clinical trials
- 41,500+ trial investigators
- 7,000+ reports on companies with products in development
- 44,000+ deals in the medical equipment industry
- 1,100+ surgical and diagnostic procedures by therapy area
- 50+ key healthcare indicators by country
- 431,000+ Themes Content Items
- 600+ Influencers
- 2000+ Analysts & Researchers
- 0.6m+ Community Members
- 1,41,000+ Macroeconomic Indicators
- 1,013,000+ City Indicators
For more information or to receive a free demonstration of the service, please visit:
https://medical.globaldata.com/home.aspx
Custom Requirements
Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.
Scope
- Market share
- Product portfolio
- Subsidiaries
- Revenue
- Pipeline products overview
- Sector analysis
- Approval timeline for pipeline products
- Pipeline products by geography
- Pipeline products by various stages of development
Reasons to Buy
- Strategic Positioning: Gain insights into Allarity Therapeutics A/S’s market share, revenue and subsidiaries.
- Strategic Alignment: Analyse the diverse product portfolio to align your strategies with industry trends.
- Strategic Navigation: Navigate the medical devices sector with in-depth sector analysis along with pipeline products and their approval timeline and geographical distribution.
Key Players
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Medical Devices reports